Winship Cancer Institute of Emory University has named two new assistant directors to support the advancement of the Winship mission, in collaboration with the Winship Executive Committee. Renee Read, PhD, has been appointed the assistant director for basic research, and Carlos Moreno, PhD, has been named the assistant director for education and training.
In her new role as assistant director, Read will work closely with Gregory Lesinski, PhD, MPH, Winship’s associate director for basic research and shared resources, to provide oversight and direction for the development and growth of basic science at Winship. Read is an associate professor in the Department of Pharmacology and Chemical Biology and Department of Hematology and Medical Oncology in the Emory University School of Medicine. Her research uses a range of experimental platforms and systems to explore the genetics and cell biology of high-grade gliomas. Her lab collaborates with clinical teams on translational research designed to identify and test new therapeutic targets for these aggressive tumor types.
“I very much look forward to working with Dr. Lesinski and Winship leadership to best support basic and translational research at Winship,” said Read. “Collaborative translational team science that brings together fundamental biology and chemistry research with complementary pharmacology and cancer medicine has the greatest potential to address unmet challenges in cancer care.”
In his new role as assistant director, Moreno will work closely with Lawrence Boise, PhD, Winship’s associate director for education and training, to lead and coordinate Winship’s research education, training and mentorship activities and cultivate additional cancer-specific educational opportunities across the spectrum of learners. Moreno is an associate professor in the Department of Pathology and Laboratory Medicine and Department of Biomedical Informatics in the Emory University School of Medicine. He is the director of the Cancer Biology Graduate Program in the Graduate Division of Biological and Biomedical Sciences at Emory University. His research focuses on identifying biomarkers and new targets for cancer therapy as well as developing novel bioinformatics methods for analysis of high-throughput genetic data.
“I am excited to be working with Dr. Boise and Winship leadership on the education and training mission at Winship,” said Moreno. “Training the next generation of cancer researchers to be rigorous scientists on the frontier of discovery has a huge impact on the field of cancer research for decades to come.”
“I am thrilled to see the Winship leadership team continue to evolve and develop with the addition of such accomplished scientists and mentors,” said Suresh Ramalingam, MD, Winship’s executive director. "Dr. Moreno and Dr. Read will add valuable expertise to support our efforts toward discovering cures and inspiring hope."